Genetic susceptibility to primary biliary cirrhosis

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 6, 1999, Pages 603-606

  Agarwal, Kaushik ^a   Jones, David E J ^a   Bassendine, Margaret F ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Autoimmunity; Biliary; Genetics; Human; Liver cirrhosis

Indexed keywords

CYTOKINE; HLA DR ANTIGEN; IMMUNOMODULATING AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

DNA POLYMORPHISM; FAMILY STUDY; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOPHENOTYPING; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032784925     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199906000-00004     Document Type: Short Survey

References (45)

1. 1 Kaplan M. Primary biliary cirrhosis. N Engl J Med 1996; 335:1570-1579.
2. 2• Leung PSC, Coppel RL, Ansari A, Munoz S, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrhosis. Semin Liver Dis 1997; 17:61-69. Good review of advances that have occurred in the last decade in the identification and characterization of the antigens reacting with PBC-specific anti-mitochondrial antibodies.
3. 3• Szostecki C, Guldner HH, Will H. Autoantibodies against nuclear dots in primary biliary cirrhosis. Semin Liver Dis 1997; 17:71-78. Good review of recent advances in the identification and characterization of some of the nuclear antigens reacting with PBC-specific anti-nuclear antibodies.
4. 4 Shimoda S, Nakamura M, Ishibishi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immunodominant T-cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune disease. J Exp Med 1995; 181:1835-1845.
5. 5 Jones DEJ. T-cell autoimmunity in primary biliary cirrhosis. Clin Sci 1996; 91:551-558.
6. 6 Crowe JP, Christensen E, Butler J, Wheeler P, Doniach D, Keenan J, et al. Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology 1980; 78:1437-1441.
7. 7 Tsianos EV, Hoofnagle JH, Fox PC, Alspaugh M, Jones EA, Schafer DF, et al. Sjogrens syndrome in primary biliary cirrhosis. Hepatology 1990; 11:730-734.
8. 8• Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol 1994; 20:698-701. Large study from North America of 405 patients with PBC which found an estimated prevalence of disease of 4.3% in family members.
9. 9 Brind AM, Bray GP, Portmann BC, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut 1995; 36:615-617.
10. 10•• Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996; 85:311-318. Excellent review of recent advances which explains how genetic analysis of animal models of autoimmunity may shed some light on human autoimmune disease.
11. 11 Kaplan MM, Rabson AR, Lee YM, Williams DL, Montaperto PA. Discordant occurrence of primary biliary cirrhosis in monozygotic twins. N Engl J Med 1994; 331:952.
12. 12 Douglas JG, Finlayson NDC. Are increased individual susceptibility and environmental factors both necessary for the development of primary biliary cirrhosis? BMJ 1979; ii:419-420.
13. 13 Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265:2037-2048.
14. 14 Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genetics 1995; 11:241-247.
15. 15 Todd JA. Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci USA 1995; 92:8560-8565.
16. 16 Bell JI, Lathrop GM. Multiple loci for multiple sclerosis. Nature Genetics 1996; 13:377-378.
17. 17 Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, et al. Nomenclature for factors of the HLA system. Hum Immunol 1997; 53:98-128.
18. 18 Ercilla G, Pares A, Arriaga F, Bruguera M, Castillo R, Rodes J, et al. Primary biliary cirrhosis associated with HLA-DRw3. Tissue Antigens 1979; 14:449-452.
19. 19 Bassendine MF, Dewar PJ, James OFW. HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut 1985; 26:625-628.
20. 20 Gores GJ, Moore SB, Fisher LD, Powell FC, Dickson ER. Primary biliary cirrhosis: associations with class II major histocompatibility antigens. Hepatology 1987; 7:889-892.
21. 21 Manns MP, Bremm A, Scheider PM, Notghi A, Gerken G, Prager-Eberle M, et al. HLA-DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 1991; 101:1367-1373.
22. 22• Underhill J, Donaldson P, Bray G, Doherty D, Portmann B, Williams R. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology 1992; 16:1404-1408. Large genotyping study of more than 100 PBC patients showing an association with HLA-DR8.
23. 23 Gregory WL, Mehal W, Dunn AN, Cavanagh G, Chapman R, Fleming KA, et al. Primary biliary cirrhosis: contribution of HLA class II allele DR8. Q J Med 1993; 86:393-399.
24. 24 Onishi S, Sakamaki T, Maeda T, Iwamura S, Tomita A, Saibara T, et al. DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J Hepatol 1994; 21:1053-1060.
25. 25 Seki T, Kiyosawa K, Ota M, Furata S, Fukushima H, Tanaka E, et al. Association of primary biliary cirrhosis with human leucocyte antigen DPB1*0501 in Japanese patients. Hepatology 1993; 18:73-78.
26. 26 Underhill JA, Donaldson PT, Doherty DG, Manabe K, Williams R. HLA DPS polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 1995; 21:959-962.
27. 27 Begovich AB, Klitz W, Moonsamy PV, Van de Water J, Peltz G, Gershwin ME. Genes within HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens 1994; 43:71-77.
28. 28• Gregory WL, Daly AK, Dunn AN, Cavanagh G, Idle JR, James OFW, et al. Analysis of HLA-class-II-encoded antigen-processing genes TAP1 and TAP2 in primary biliary cirrhosis. Q J Med 1994; 87:237-244. Large genotyping study of more than 100 PBC patients which found no evidence for involvement of antigen-processing genes in genetic predisposition to PBC.
29. 29 Potter BJ, Elias E, Jones EA. Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis. J Lab Clin Med 1976; 88:427-439.
30. 30 Briggs DC, Donaldson PT, Hayes P, Welsh KI, Williams R, Neuberger JM. A major histocompatibility complex class III allotype (C4B2) associated with primary biliary cirrhosis (PBC). Tissue Antigens 1987; 29:141-145.
31. 31 Mehal WZ, Gregory WL, Lo Y-MD, Cross SJ, Fleming KA, Bassendine MF, et al. Defining the immunogenetic susceptibility to primary biliary cirrhosis. Hepatology 1994; 20:1213-1219.
32. 32 Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumour necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177:557-560.
33. 33 Wilson AG, Gordon C, di Giovine FS, de Vries N, van der Putte LBA, Emery P, et al. A genetic association between systemic lupus erythematosus and tumour necrosis factor alpha. Eur J Immunol 1994; 24:191-195.
34. 34 Gressner AM. Mediators of hepatic fibrogenesis. Hepatogastroenterology 1996; 43:92-103.
35. 35 Gordon MA, Gleeson D, Oppenheim E, di Giovine FS, Camp NC, Duff GW. Tumour necrosis factor genetic polymorphisms and primary biliary cirrhosis [Abstract]. Hepatology 1996; 24:166A.
36. 36• Jones DEJ, Watt FE, Grove J, Daly AK, Day CP, James OFW, et al. Tumor necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis. J Hepatol 1999; 30:232-236. Large genotyping study of more than 100 PBC patients showing a significantly increased frequency of the -308 TNF1/TNF1 genotype in 95 patients with more advanced disease, raising the possibility that this allele may be linked to disease progression rather than susceptibility. The finding of different allele frequencies in PBC patients in different disease subgroups emphasizes the importance of clinical phenotype/case mix in the design of disease association studies.
37. 37 Berg PA, Klein R, Rocken M. Cytokines in primary biliary cirrhosis. Semin Liver Dis 1997; 17:117-123.
38. 38 Abbas AK, Murphy KM, Ser A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-793.
39. 39 Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. IL-10 deficient mice develop chronic enterocolitis. Cell 1993; 75:263-274.
40. 40• Zappala F, Grove J, Watt FE, Daly AK, Day CP, Bassendine MF, et al. No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis. J Hepatol 1998; 28:820-823. Another large genotyping study of more than 100 PBC patients.
41. 41 Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, Degroot LJ. CTLA-4 gene polymorphism. J Clin Endocrinol Metab 1995; 80:41-45.
42. 42 Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997; 7:445-450.
43. 43 Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol 1997; 158:1989-1993.
44. 44 Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, et al. CTLA-4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 1997; 82:143-146.
45. 45 Agarwal K, Grove J, Pearce S, Daly A, Jones DEJ, Bassendine MF. CTLA-4 gene polymorphism associated with primary biliary cirrhosis [Abstract]. Hepatology 1998; 28:404A.